Physician profile
Anup Banerjee
NPI 1740213263
$19,072.92
in general payments reported to CMS, 2019-2025
67 companies · $4,019 in 2025
The $4,019 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,206 · 2020: $1,161 · 2021: $1,804 · 2022: $3,322 · 2023: $3,026 · 2024: $2,534 · 2025: $4,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,716 · Travel and Lodging: $2,763 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,715.53 |
| Travel and Lodging | $2,763.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,873.32 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Chiesi USA, INC. | $2,587.73 | 2025 | |
| Glaxosmithkline, LLC. | $2,302.21 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Uk Limited | $1,204.60 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $970.39 | 2019-2025 | Ofev, Stiolto Respimat |
| Novo Nordisk INC | $741.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $703.18 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Actelion Pharmaceuticals US, INC. | $581.26 | 2019-2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $546.57 | 2019-2024 | Xarelto |
| Resmed Corp | $519.26 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $504.38 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $455.58 | 2019-2024 | Yupelri |
| Insmed, INC. | $423.51 | 2019-2024 | Arikayce |
| Amgen INC. | $394.23 | 2019-2025 | Otezla, Repatha, Repatha |
| Genzyme Corporation | $383.88 | 2021-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $316.99 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $315.59 | 2022-2025 | Acthar |
| Philips North America LLC | $270.17 | 2019-2022 | |
| Radius Health, INC. | $255.33 | 2019-2025 | Tymlos |
| Verona Pharma, INC. | $211.45 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $193.27 | 2022-2025 | Wakix |
| Merck Sharp & Dohme LLC | $187.00 | 2019-2024 | Capvaxive, Zerbaxa, Vaxneuvance |
| Avadel Cns Pharmaceuticals, LLC | $169.95 | 2024-2025 | Lumryz |
| Amarin Pharma, INC. | $158.62 | 2019-2021 | |
| Pfizer INC. | $140.42 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $132.54 | 2021-2024 | |
| Electromed, INC. | $129.16 | 2021-2024 | Smartvest |
| Grifols USA, LLC | $122.35 | 2019-2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $78.38 | 2023-2025 | Inspire |
| Inogen, INC. | $78.38 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Sunovion Pharmaceuticals INC. | $74.57 | 2019 | |
| Circassia INC. | $72.60 | 2019-2020 | |
| Abbvie INC. | $66.87 | 2021-2023 | Vraylar |
| Abbott Laboratories | $64.35 | 2021-2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $60.71 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.61 | 2020-2023 | Glassia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.50 | 2019-2022 | |
| Genentech USA, INC. | $56.10 | 2019-2022 | |
| Pulmonx Corporation | $49.82 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Novartis Pharmaceuticals Corporation | $46.99 | 2021-2024 | |
| Masimo Corporation | $46.01 | 2020 | |
| Viatris Specialty LLC | $45.62 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $42.05 | 2021-2022 | |
| Nabriva Therapeutics, Plc | $40.65 | 2021-2022 | |
| Shield Therapeutics INC | $38.69 | 2023-2024 | Accrufer |
| Eisai INC. | $37.87 | 2020-2021 | |
| Axsome Therapeutics, INC. | $28.80 | 2023 | Sunosi |
| Baxter Healthcare | $28.71 | 2023 | Hillrom - Life 2000 Ventilation System |
| Astellas Pharma US INC | $20.18 | 2019 | |
| Verity Pharmaceuticals INC. | $17.05 | 2024 | Tlando |
| Mallinckrodt Enterprises LLC | $16.85 | 2019 | |
| Cequr Corporation | $16.75 | 2023 | Cequr Simplicity |
| Dexcom, INC. | $14.94 | 2024 | Dexcom G6 Transmitter |
| Almatica Pharma LLC | $14.19 | 2025 | Teriparatide |
| E.R. Squibb & Sons, L.L.C. | $14.05 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.58 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $13.35 | 2023 | Fisher & Paykel Healthcare |
| Optinose US, INC. | $12.94 | 2020 | |
| Advanced Respiratory, INC | $12.38 | 2020 | |
| Daiichi Sankyo INC. | $12.37 | 2019 | |
| Esperion Therapeutics, INC. | $11.97 | 2021 | |
| Tactile Systems Technology INC | $11.28 | 2021 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,033.84 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anup Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.